Log in
Enquire now

List of Titan Pharmaceuticals patents

List of Titan Pharmaceuticals patents
List of Tearscience, Inc. patents
List of Energizer patents
List of West Pharmaceutical Services patents
List of funding rounds for ShipBob
List of funding rounds for Kromek
Patents where
Current Assignee
Name
is
Titan PharmaceuticalsTitan Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10123971 Heterogeneous implantable devices for drug delivery

Patent 10123971 was granted and assigned to Titan Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.

Titan Pharmaceuticals
Titan Pharmaceuticals
Titan Pharmaceuticals
Titan Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10123971
November 13, 2018
‌
US Patent 10111830 Heterogeneous implantable devices for drug delivery

Patent 10111830 was granted and assigned to Titan Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.

Titan Pharmaceuticals
Titan Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10111830
October 30, 2018
‌
US Patent 7736665 Implantable polymeric device for sustained release of buprenorphine

Patent 7736665 was granted and assigned to Titan Pharmaceuticals on June, 2010 by the United States Patent and Trademark Office.

Titan Pharmaceuticals
Titan Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7736665
June 15, 2010
‌
US Patent 8852623 Implantable polymeric device for sustained release of dopamine agonist

Patent 8852623 was granted and assigned to Titan Pharmaceuticals on October, 2014 by the United States Patent and Trademark Office.

Titan Pharmaceuticals
Titan Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8852623
October 7, 2014
‌
US Patent 9278163 Implantable polymeric device for sustained release of dopamine agonist

Patent 9278163 was granted and assigned to Titan Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.

Titan Pharmaceuticals
Titan Pharmaceuticals
Titan Pharmaceuticals
Titan Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9278163
March 8, 2016
5 results
0 selected
5 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us